Top compounds associated with response to SPNS2


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0099 0.8
mRNA etoposide CTRPv2 pan-cancer AAC -0.0086 0.8
mRNA tandutinib CTRPv2 pan-cancer AAC -0.01 0.8
mRNA Cisplatin GDSC1000 pan-cancer AAC -0.01 0.8
mRNA betulinic acid CTRPv2 pan-cancer AAC -0.011 0.8
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC -0.013 0.8
mRNA quizartinib CTRPv2 pan-cancer AAC -0.011 0.8
mRNA QL-X-138 GDSC1000 pan-cancer AAC -0.0091 0.8
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.033 0.8
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.0087 0.8
Download CSV